Anne Schlegel

Anne Schlegel is a Senior Regulatory Scientist at Voisin Consulting Life Sciences (VCLS) since March 2021. Prior to that, Anne was the Head of "Formulation Discovery and Testing" at BioNTech SE from January 2016 to May 2019. With a background in biotechnology and pharmacy, Anne has worked on the development of nucleic acid delivery systems for cancer immunotherapy and infectious diseases vaccines. Anne has also held positions at BioNTech AG, DNA Therapeutics, PX Therapeutics, and New England Biolabs, gaining experience in R&D, project management, and protein production. Anne holds a Master's degree in Development and registration of medicinal products, a PhD in biotechnology, and a diplôme d'Ingénieur in biotechnology.